Soltis Investment Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Soltis Investment Advisors's MDT Position: Q2 2026 in Review
Soltis Investment Advisors increased its Medtronic (MDT) stake by 6.5% in Q2 2026, buying an estimated $655K and bringing the position to 132,646 shares worth $10.4M. The position accounts for 0.58% of the portfolio, ranked #40.
Soltis Investment Advisors first reported a position in MDT in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.8M in Q1 2026. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Soltis Investment Advisors held 132,646 shares of Medtronic worth $10.4M as of Q2 2026.
- Soltis Investment Advisors bought 8,114 Medtronic shares in Q2 2026, an estimated $655K.
- Medtronic made up 0.58% of Soltis Investment Advisors's portfolio in Q2 2026, its #40 holding.
- Soltis Investment Advisors first reported a position in Medtronic in Q4 2020 and has held it in 23 quarters since.
- Soltis Investment Advisors's Medtronic position peaked at $10.8M in Q1 2026.
- 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.